Ophthalmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018

MarketResearchReports.Biz announces addition of new report"Ophthalmic Drugs Market (Dry Eye, Anti-Glaucoma, Anti-Allergy/Inflammatory/Infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018"to its database


Albany, NY -- (SBWIRE) -- 07/17/2014 -- The global ophthalmic drugs market is rapidly growing due to increasing prevalence of eye disorders such as glaucoma, dry eye diseases and retinal diseases. Changing lifestyle, improved medical infrastructure, technological changes, increase in healthcare spending and aging population is also supporting the growth of the ophthalmic drugs market.

Global ophthalmic drugs market was valued at USD 16 billion in 2012 and is expected to grow at a CAGR of 5.2% from 2013 to 2018, to reach an estimated value of USD 21.6 billion in 2018.

Glaucoma is the largest drugs segment in global ophthalmic drugs market. Some of the major drugs for glaucoma treatment are Lumigan, Combigan, Xalatan, Ganfort and Saflutan. Diquas, Hyalein and Restasis are the major drugs for dry eye diseases. The retinal drugs market includes Ozurdex, Macugen, Visudyne and Lucentis. Patanol/Pataday, Tobradex, Vigamox and Bepreve are major ocular anti-inflammatory drugs. The ophthalmic drugs market covers prescription based drugs, OTC drugs and pipeline drugs. This report forecasts future potential of all these drug markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter’s forces, competitive landscape and company profiles of key players.

Get Complete Report at

The report categorizes the global ophthalmic drugs market based on major eye disorders, treatment drugs and geography. The treatment drugs market comprises treatment of major eye disorders such as glaucoma, dry eye drugs, retinal diseases and ocular inflammatory diseases. The market is further segmented on the basis of prescription based drugs, OTC drugs and pipeline drugs in different eye disorder areas. In the segment of geographic analysis, the report identifies and analyses market sizes and forecast of North America, Europe, Asia Pacific and Rest of the World (RoW). North America region covers the scenario of the US. Europe region covers the scenario of France, Germany and the UK. Asia Pacific region highlights the scenario of India, China and Japan.

The global ophthalmic drugs market is segmented as follows:

Ophthalmic Drugs Market, By Treatment Drugs

Dry Eye Drugs
Retinal Drugs
Anti-inflammatory/allergy/infective Drugs
Anti-glaucoma Drugs

Ophthalmic Drugs Market, By Types

Prescription Drugs
OTC Drugs

Ophthalmic Drugs Market, by Geography

North America
Asia Pacific
Rest of the World (RoW)

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Find More Latest Market Research Articles -